IRVINE, Calif., Oct. 18, 2024 /PRNewswire/ — Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the U.S. FDA approval of Botox Cosmetic for temporary improvement in the appearance of moderate to severe vertical bands connecting…Original Article
You may also like
FDA Approves Orlynvah (sulopenem etzadroxil and...
U.S. FDA Approves Pfizer’s RSV Vaccine Abrysvo for...
Alvotech and Teva Announce U.S. FDA Approval of...
FDA Approves Vyloy (zolbetuximab-clzb) for the...
Avadel Pharmaceuticals Announces FDA Approval of...
UCB Receives U.S. FDA Approval for 320 mg...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.